Viewing nowCivix Tablet (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Searis Pharmaceutical Co., Ltd.

MFDS item code 202002447 · Approved 2020.04.07 · Insurance code 689001260
Treatment of moderate to severe Alzheimer's disease
This medication is used to treat moderate to severe Alzheimer's disease.
This medication is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg each week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7) Administer 5mg once daily for 7 days. Week 2 (Days 8–14) Administer 10mg once daily for 7 days. Week 3 (Days 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. Older adults: Based on clinical data, the recommended dose for patients aged 65 years or older is 20mg once daily. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If the medication is well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Because there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.
This drug should not be used in patients with hypersensitivity to its components, severe liver dysfunction, or kidney dysfunction. Particularly in cases of significantly decreased kidney function, administration should be avoided. Care should be taken when administering to patients with epilepsy or those with a history of seizures, as well as to those with a predisposition to seizures. Furthermore, taking this medication in combination with other NMDA antagonists may increase side effects, so co-administration should be avoided. Patients with factors or conditions that increase the pH of urine should have their drug effects and side effects monitored closely. The safety of this medication has not been adequately established in patients with recent myocardial infarction, congestive heart failure, or uncontrolled hypertension, so it should be used cautiously in these patients. During treatment, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and it is important to consult healthcare professionals if these symptoms arise. This medication can interact with various drugs, so it is essential to inform healthcare professionals if other medications are being taken. Care should be taken when combining with NMDA antagonists, antipsychotic medications, skeletal muscle relaxants, anticoagulants, etc. Pregnant women or those who may become pregnant should consult a doctor before using this medication, and breastfeeding women are advised to discontinue breastfeeding since this medication may pass into breast milk. It is recommended not to use this medication in children or adolescents under 18 years old, as its safety and efficacy have not been established in this population. In cases of overdose, central nervous system symptoms and gastrointestinal symptoms may appear, necessitating immediate medical attention for appropriate treatment. This medication may impair the patient’s responsiveness, so care should be taken when driving or operating machinery. Finally, this medication should be kept out of the reach of children, and transferring it to other containers may lead to a deterioration in quality or accidents, so care must be taken.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius to ensure the prolonged effectiveness and safety of the medication.
White oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Searis Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.